Stockscreener 앱 받기
84.80
1.07%
0.90
시간 외 거래:
84.86
0.06
+0.07%
Incyte Corp 주식(INCY)의 최신 뉴스
Bank of America Securities Maintains a Buy Rating on Incyte Corporation (INCY), Sets a $104 PT - ca.finance.yahoo.com
INCY Announces New Late-Stage Data on Skin Disease Drug - Yahoo Finance
Retail Trends: Is JZXN in a long term uptrend2025 Earnings Surprises & Low Risk Entry Point Tips - خودرو بانک
Povorcitinib shows promising results for hidradenitis suppurativa By Investing.com - Investing.com Canada
Is Incyte Corporation impacted by rising ratesPortfolio Value Report & Free Verified High Yield Trade Plans - خودرو بانک
INCY: Incyte Unveils Promising Interim Data for Povorcitinib in Phase 3 Trials - GuruFocus
Invst LLC Makes New Investment in Incyte Corporation $INCY - MarketBeat
Incyte’s povorcitinib shows strong results in hidradenitis suppurativa trial - Investing.com
Alliancebernstein L.P. Has $14.55 Million Stake in Incyte Corporation $INCY - MarketBeat
Povorcitinib shows promising results for hidradenitis suppurativa - Investing.com
Severe Asthma Market Insights Highlight Expanding Outlook Till - openPR.com
60% Patient Response: Incyte's New Drug Shows Strong Promise in Treating Severe Skin Disease at 24 Weeks - Stock Titan
Severe Asthma Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Sanofi, GlaxoSmithKline, EMS, Oneness Biotech, Incyte Corp, CSPC ZhongQi Pharma, AstraZeneca - Barchart.com
OMNI 360 Wealth Inc. Acquires New Stake in Incyte Corporation $INCY - MarketBeat
Kera Capital Partners Inc. Invests $339,000 in Incyte Corporation $INCY - MarketBeat
Incyte (NASDAQ:INCY) Cut to Buy at Wall Street Zen - MarketBeat
Royal Bank of Canada Sells 14,218 Shares of Incyte Corporation $INCY - MarketBeat
Ashton Thomas Private Wealth LLC Raises Position in Incyte Corporation $INCY - MarketBeat
5,260 Shares in Incyte Corporation $INCY Bought by MBB Public Markets I LLC - MarketBeat
Polycythemia Vera Market: Epidemiology, Treatment Landscape, and Key Players | Incyte, Novartis, PharmaEssentia, AOP Orphan Pharmaceuticals, Protagonist Therapeutics, Merck (Imago BioSciences), Italfa - Barchart.com
Update Recap: Is Incyte Corporation impacted by rising ratesPrice Action & Daily Volume Surge Signals - خودرو بانک
Woodline Partners LP Grows Holdings in Incyte Corporation $INCY - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $95.86 Million Stock Holdings in Incyte Corporation $INCY - MarketBeat
Empowered Funds LLC Buys 115,225 Shares of Incyte Corporation $INCY - MarketBeat
Great Lakes Advisors LLC Grows Position in Incyte Corporation $INCY - MarketBeat
Incyte Corporation (NASDAQ:INCY) Sees Large Growth in Short Interest - MarketBeat
Incyte Corporation $INCY Shares Sold by Amundi - MarketBeat
Incyte Corporation $INCY Shares Acquired by Acadian Asset Management LLC - MarketBeat
Raymond James Financial Inc. Buys 17,313 Shares of Incyte Corporation $INCY - MarketBeat
Incyte Corporation (INCY) Advances KRAS Cancer Program - Yahoo Finance
Caxton Associates LLP Takes $1.67 Million Position in Incyte Corporation $INCY - MarketBeat
Incyte Corporation $INCY Stock Position Raised by Jacobs Levy Equity Management Inc. - MarketBeat
Incyte Corporation $INCY Shares Acquired by Federation des caisses Desjardins du Quebec - MarketBeat
Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress - Yahoo Finance
Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More - Yahoo Finance
Incyte at Morgan Stanley Healthcare: Strategic Focus on Innovation - Investing.com
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? - MSN
The truth behind Incyte’s HS Truths educational push - Medical Marketing and Media
Chronic Hand Eczema Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Incyte Corp, LEO Pharma, Asana BioSciences, Arcutis Biotherapeut - Barchart.com
AQR Capital Management LLC Boosts Stock Position in Incyte Corporation $INCY - MarketBeat
Nomura Holdings Inc. Has $936,000 Stake in Incyte Corporation $INCY - MarketBeat
Former Pfizer Oncology Chief and $4.2B Incyte Leader Join Bicycle Therapeutics' Board of Directors - Stock Titan
Canada Pension Plan Investment Board Grows Position in Incyte Corporation $INCY - MarketBeat
Focus Partners Advisor Solutions LLC Invests $1.32 Million in Incyte Corporation $INCY - MarketBeat
Incyte (NASDAQ:INCY) Sets New 52-Week HighHere's What Happened - MarketBeat
Incyte’s Pipeline And Profits Shine Despite Patent Uncertainty - Finimize
First Financial Bankshares Inc Grows Holdings in Incyte Corporation $INCY - MarketBeat
Incyte (INCY) Rating Affirmed with Increased Price Target by B o - GuruFocus
Can trapped investors hope for a rebound in Incyte CorporationTrade Ideas & Technical Pattern Based Signals - Newser
Corebridge Financial Inc. Boosts Holdings in Incyte Corporation $INCY - MarketBeat
Is Incyte Corporation forming a bullish divergence2025 Momentum Check & Capital Protection Trade Alerts - خودرو بانک
0.62%
0.57%
자본화:
|
볼륨(24시간):